Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
07/21/1994 | WO1994015592A1 Compositions comprising cholesterol lowering agents and antioxidants |
07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
07/21/1994 | CA2153698A1 Olefin-substituted long chain compounds |
07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
07/21/1994 | CA2152184A1 Thiazolidine derivatives; process for preparing the same and drugs containing them |
07/21/1994 | CA2131370A1 Quinoline-3-acetic acid derivative, process for production thereof and use thereof |
07/20/1994 | EP0606824A1 Substituted dialkylthioethers |
07/20/1994 | EP0606742A1 Bile acid sequestrant |
07/20/1994 | EP0606332A1 Method of producing starch decomposition products with a narrow molecular-weight distribution |
07/20/1994 | EP0606318A1 Vanadium compositions |
07/20/1994 | CN1089614A Alpha-phosphonosulfonate squalene synthetase inhibitors and method |
07/20/1994 | CN1089599A Derivative of vitamin D system which is modified in 20-position, preparation of same and pharmaceutical made of same |
07/20/1994 | CA2113580A1 Organic compounds |
07/19/1994 | US5331009 Pharmaceutical compositions for treating adrenoleukodystrophy |
07/19/1994 | US5330999 2,4-thiazolidinedione compounds |
07/19/1994 | US5330977 Di-N-acetyl lysoganglioside compositions |
07/19/1994 | US5330757 Method for the prevention and reversal of the extrinsic aging of the skin by transdermal application of selenamino acids and compositions therefore |
07/19/1994 | CA1330806C Vitamin d_ derivatives having a substituent at 2-position |
07/16/1994 | CA2112786A1 Substituted dialkylthio ethers |
07/13/1994 | EP0606049A1 Aminoalkylphenyl compounds |
07/13/1994 | EP0605983A2 Insulin analogs |
07/13/1994 | EP0605913A1 Use of bile salt-activated lipase as dietary supplement |
07/13/1994 | EP0605728A1 Chromone derivative and aldose reductase inhibitor containing the same as active ingredient |
07/13/1994 | EP0605484A1 Peptides having growth hormone releasing activity |
07/13/1994 | EP0559751A4 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
07/12/1994 | US5328909 Cyclopropenone derivatives |
07/12/1994 | US5328906 0-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
07/12/1994 | US5328903 Containing mannitol or sugar, hydroxypropyl cellulose, and polyvinylpyrrolidone or hydroxymethyl celulose; stabilization, uniform distribution |
07/12/1994 | US5328891 DNA codes and proteins |
07/12/1994 | US5328470 Catheter |
07/12/1994 | CA1330663C Thiazolidinedione derivatives |
07/07/1994 | WO1994014843A1 Endothelin antagonists |
07/07/1994 | WO1994014786A1 Piperidine derivatives as calcium channel antagonists |
07/07/1994 | WO1994014766A1 Novel vitamin d analogues |
07/07/1994 | WO1994014461A1 Insulin analogs |
07/07/1994 | WO1994014435A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
07/07/1994 | WO1994014433A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A β-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |
07/07/1994 | WO1994014429A1 Method of promoting nitrogen retention in humans |
07/07/1994 | WO1994014411A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis |
07/07/1994 | WO1994014347A1 A protective garment |
07/07/1994 | CA2152912A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
07/07/1994 | CA2152394A1 Piperidine derivatives as calcium channel antagonists |
07/07/1994 | CA2152163A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis |
07/07/1994 | CA2151134A1 Insulin analogs |
07/07/1994 | CA2146874A1 Endothelin antagonists |
07/07/1994 | CA2112778A1 Aminoalkylphenyl compounds |
07/06/1994 | EP0605230A1 Hexanhydronaphthalene ester derivatives, their preparation and their therapeutic uses |
07/06/1994 | EP0605228A1 Thiazolidinedione derivatives, their production and use |
07/06/1994 | EP0605193A1 Use of benzothiophenes for treatment of hypercholesterolaemia |
07/06/1994 | EP0604983A1 Naphthalene derivatives |
07/06/1994 | EP0604800A1 4- 4- 4-(carboxyalkyl)-phenyl amino carbonyl -phenyl -piperedines as aggregation inhibitors |
07/06/1994 | CN1088835A Use of a peptide |
07/05/1994 | US5326898 Substituted phenylethenyl compounds having retinoid-like biological activity |
07/05/1994 | US5326757 Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
07/05/1994 | CA1330561C Synthetic gtf chromium material and process therefor |
07/01/1994 | CA2086565A1 Pharmaceutical composition for treating pigmentation |
06/29/1994 | EP0603769A1 Alpha-Aminoketone derivatives |
06/29/1994 | EP0603699A1 Substituted pyridines as HMG-CoA reductase inhibitors |
06/29/1994 | EP0603649A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors |
06/29/1994 | EP0480934B1 A slimming pharmaceutical composition |
06/29/1994 | EP0470183B1 Fibroblast growth factor conjugates |
06/29/1994 | EP0406272B1 Production of insulin-like growth factor binding protein |
06/29/1994 | CN1088583A Phospholipi derivatives containing higher elements of the Vth main group |
06/29/1994 | CA2112442A1 Hexahydroaphthalene ester derivatives, their preparation and their therapeutic uses |
06/29/1994 | CA2112283A1 Thiazolidinedione derivatives, their production and use |
06/28/1994 | US5324840 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
06/28/1994 | US5324749 Pharmaceutical aqueous solution of 4-[2-(benzene-sulphonylamino)-ethyl]-phenoxyacetic acid |
06/28/1994 | US5324742 Antidiabetic agents |
06/28/1994 | CA1330441C Process for trans-6-[2-(substituted-pyrrol-1-yl) alkyl] pyran-2-one inhibitors of cholesterol synthesis |
06/28/1994 | CA1330420C Compositions containing growth hormone peptide fragments |
06/28/1994 | CA1330417C Organic compounds |
06/26/1994 | CA2111931A1 .alpha.-aminoketone derivatives |
06/23/1994 | WO1994013816A1 Recombinant canine gastric lipase and pharmaceutical compositions |
06/23/1994 | WO1994013696A1 Spiro piperidines and homologs which promote release of growth hormone |
06/23/1994 | WO1994013676A1 Pyrrolopyrimidines as crf antagonists |
06/23/1994 | WO1994013650A1 Heterocyclic derivatives and their use in pharmaceuticals |
06/23/1994 | WO1994013645A1 Novel selective aromatase inhibiting compounds |
06/23/1994 | WO1994013319A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
06/23/1994 | WO1994013300A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
06/23/1994 | WO1994013291A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives |
06/23/1994 | WO1994013278A1 Methods for treatment with dimercaptosuccinic acid (dmsa) |
06/23/1994 | WO1994013276A1 4-guanidinobutyramide for improving blood circulation |
06/23/1994 | WO1994013275A1 Glaucoma treatment |
06/23/1994 | CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
06/23/1994 | CA2151747A1 Methods for treatment with dimercaptosuccinic acid (dsma) |
06/23/1994 | CA2151734A1 4-guanidinobutyramide for improving blood circulation |
06/23/1994 | CA2150904A1 Novel selective aromatase inhibiting compounds |
06/22/1994 | EP0602211A1 Use of growth factor igf-ii |
06/22/1994 | EP0602172A1 A method for treatment of patients with chronic liver disease |
06/22/1994 | EP0602149A1 Composition and method for reducing cholesterol concentration |
06/22/1994 | EP0602026A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it |
06/22/1994 | CA2111778A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines |
06/22/1994 | CA2111631A1 Bile acid sequestrant |
06/21/1994 | US5322848 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
06/21/1994 | US5322697 Composition and method for inducing satiety |
06/21/1994 | CA1330344C Tetrahydrocarbazole esters |
06/21/1994 | CA1330304C Tissue irrigating solution |
06/16/1994 | DE4241632A1 New (aza)aromatic or alicyclic carboxylic acid cpds. - used e.g. for treating thrombosis, inflammation, osteoporosis, cardiac infarct or tumour metastasis |
06/15/1994 | EP0601573A1 Alpha-phosphonocarboxylate squalene synthetase inhibitors and method |
06/15/1994 | EP0601135A1 Osteogenic proteins in the treatment of bone diseases |